Q1 2025 Holdings
Filed 2025-05-15 | 123 holdings | $5.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $8.5M | 225,000 | 0.2% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $8.5M | 812,408 | 0.2% |
| Simulations Plus Inc(SLP) | COM | 829214105 | $8.7M | 354,089 | 0.2% |
| Rxsight Inc(RXST) | COM | 78349D107 | $9.9M | 392,332 | 0.2% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $10.2M | 925,000 | 0.2% |
| Delcath SYS Inc(DCTH) | COM NEW | 24661P807 | $10.4M | 813,106 | 0.2% |
| Opko Health Inc(OPK) | COM | 68375N103 | $11.5M | 6,906,362 | 0.2% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $11.6M | 650,119 | 0.2% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $11.9M | 3,255,514 | 0.2% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $12.3M | 1,562,942 | 0.2% |
| Beta Bionics Inc(BBNX) | COM | 08659B102 | $12.4M | 1,016,000 | 0.2% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $12.7M | 1,890,000 | 0.3% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $13.1M | 1,503,594 | 0.3% |
| Docgo Inc(DCGO) | COM | 256086109 | $13.3M | 5,051,500 | 0.3% |
| Metsera Inc | COM | 59267L107 | $13.6M | 500,000 | 0.3% |
| Concentra Group Holdings PAR(CON) | COMMON STOCK | 20603L102 | $14.1M | 650,000 | 0.3% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $15.1M | 6,710,429 | 0.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $15.8M | 2,633,862 | 0.3% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $16.2M | 593,000 | 0.3% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $17.1M | 877,809 | 0.3% |
| Integra Lifesciences Hldgs C(IART) | COM NEW | 457985208 | $17.5M | 794,865 | 0.3% |
| Xeris Biopharma Holdings Inc | NOTE 8.000% 7/1 | 98422EAB9 | $19.9M | $10,500,000 | 0.4% |
| Certara Inc(CERT) | COM | 15687V109 | $20.0M | 2,022,616 | 0.4% |
| Establishment Labs Hldgs Inc(ESTA)Put | COM | G31249108 | $20.4M | 500,000 | 0.4% |
| CG Oncology Inc(CGON) | COM | 156944100 | $20.8M | 850,695 | 0.4% |
| Savara Inc(SVRA) | COM | 805111101 | $22.1M | 7,964,000 | 0.4% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $23.4M | 240,218 | 0.5% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $23.5M | 619,931 | 0.5% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $23.5M | 2,960,740 | 0.5% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $23.8M | 1,616,778 | 0.5% |
| Immunocore Hldgs PLC | NOTE 2.500% 2/0 | 45258DAB1 | $25.2M | $30,000,000 | 0.5% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $25.2M | 1,050,000 | 0.5% |
| Phreesia Inc(PHR) | COM | 71944F106 | $25.8M | 1,009,844 | 0.5% |
| Inmode LTD(INMD) | SHS | M5425M103 | $28.0M | 1,578,708 | 0.6% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $29.2M | 3,860,839 | 0.6% |
| Pharvaris N V(PHVS) | COM | N69605108 | $31.7M | 2,017,464 | 0.6% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $32.1M | 3,771,342 | 0.6% |
| Embecta Corp(EMBC) | COMMON STOCK | 29082K105 | $34.7M | 2,720,535 | 0.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $34.9M | 458,000 | 0.7% |
| Envista Holdings Corporation(NVST) | COM | 29415F104 | $35.0M | 2,024,943 | 0.7% |
| Lantheus Hldgs Inc | NOTE 2.625%12/1 | 516544AB9 | $35.6M | $25,255,000 | 0.7% |
| Conmed Corp(CNMD) | COM | 207410101 | $36.9M | 611,000 | 0.7% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $38.8M | 782,333 | 0.8% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $38.9M | 5,189,665 | 0.8% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $39.2M | 145,000 | 0.8% |
| Enhabit Inc(EHAB) | COM | 29332G102 | $43.9M | 4,997,746 | 0.9% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $45.6M | 21,231,974 | 0.9% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $45.7M | 2,078,509 | 0.9% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $53.5M | 3,267,551 | 1.1% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $55.1M | 226,070 | 1.1% |